Advancing the systematics of Araneae: ultraconserved elements phylogenomics demonstrates the non-monophyly of Miturgidae Simon, 1886 and supports the Familial Rank of Systariidae Deeleman-Reinhold, 2001

  Advancing the systematics of Araneae: ultraconserved elements phylogenomics demonstrates the non-monophyly of Miturgidae Simon, 1886 and supports the Familial Rank of Systariidae Deeleman-Reinhold, 2001 Abstract The systematic status of the family Miturgidae Simon, 1886 and related subfamilies has long been problematic, primarily due to challenges in interpreting morphological characters and limited molecular sampling. In this study, we reconstruct the phylogeny of Miturgidae using ultraconserved elements and estimate its divergence time. Our results suggest that Systariinae does not belong to Miturgidae, but rather is sister to all other families of the Dionycha B clade. Consequently, we elevate it to family rank as Systariidae Deeleman-Reinhold, 2001 and discuss its morphological synapomorphies. Furthermore, our analyses place Miturgidae as the sister clade to Viridasiidae + Selenopidae under multiple phylogenetic methods. Divergence time estimates indicate an ancient origin of...

Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins

 


Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins

Abstract

Currently, commercially available pain medications can cause adverse effects. Within this framework, researchers have been exploring new drug candidates derived from animal venoms and toxins. The objective of this study was to investigate the number of molecules with potential for pain relief derived from animal venoms and toxins, which could potentially contribute to the development of new biopharmaceuticals. We conducted a literature search in January 2025, covering the period from 1960 to 2025, in two Latin American and nine international scientific databases. The results consisted of 212 articles selected for review. From these articles, 152 toxins and venoms with analgesic potential were identified and classified into 14 different types of pharmacological targets. The peptides investigated, with masses between 500 Da and 5000 Da, are strong candidates for alternative biopharmaceuticals. Most of the toxins found interact with ion channels, representing an alternative to commercially available drugs.

Angstmam, D. G., Jeronimo, B. C., Cavalcante, J. D., Pereira, A. F., Villarreal, C. F., Pimenta, D. C., & Ferreira Junior, R. S. (2026). Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins. Toxins, 18(2), 69. https://doi.org/10.3390/toxins18020069